The rating is based on a number of factors, including SJHS’ large scale, essential role as a safety-net provider and strong operating cash flow generation. Offsetting these strengths are SJHS’ location in a competitive service area and its heavy reliance on governmental payers.
The outlook is stable, reflecting Moody’s Investors Service’s expectation that SJHS will produce operating cash flow margins around 10 percent.
Moody’s also affirmed the “Baa3” rating on SJHS’ outstanding revenue bonds.
More articles on healthcare finance:
Hospitals need new strategies for managing uncompensated care risks
Conn. cost containment plan would create consumer care networks
OIG: St. Louis hospital received $341k in Medicare overpayments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
